Cancer Gene Panel and Profiling Market Surge: Projected CAGR of 15.5% from 2024 to 2029

Market Overview: Cancer Gene Panel and Profiling Market FY23-28

This reports provides an essential and dependable overview of the Cancer Gene Panel and Profiling Market, serving as a guide for stakeholders navigating the industry’s future trajectory. It covers critical aspects, guiding through challenges and opportunities, shedding light on the market landscape, key insights, driving forces, major competitors, regulatory framework, potential growth, ongoing trends, supply chain dynamics, evolving policies, segments and prominent players.

Cancer Gene Panel and Profiling Market Report Coverage Details:

• Base Year: 2023
• Historical Data: 2019-22
• Forecast Period: 2024-2029
• CAGR: 5% (2024-2029)

The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Boost strategic growth with in-depth market analysis — Get a free sample preview today!- https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html

Cancer Gene Panel and Profiling Market Opportunity:

Rising Development of Personalized Medicine – Cancer gene panels and profiling services are projected to experience substantial growth in the future, owing to their potential efficacy in personalized cancer treatment. As gene panel and profiling services have the potential to identify patients with specific genetic characteristics that are likely to respond to various treatment methods, it is expected to broaden their market potential. This approach would improve the safety profile of cancer patients by reducing the potential for adverse effects & toxicity associated with personalized drugs.

In addition, hospitals & cancer research centers in recent years have been focussing on providing personalized treatment services to their cancer patients, especially across countries like India, the UK, etc. For instance:

• In 2023, the UK Government and BioNTech SE entered into a memorandum of understanding (MoU), which aims to enhance cancer patients’ access to cutting-edge trials & therapies in development and to extend personalized cancer treatments to more patients.

Consequently, as the provision of personalized treatment increases across the globe, the demand for cancer gene panels and profiling services would also amplify. Hence, the rising inclination toward personalized medicines would represent a significant opportunity for the Cancer Gene Panel and Profiling Market growth in the forecast years.

Cancer Gene Panel and Profiling Market Segmentation Analysis — FY23-28

Discover a comprehensive evaluation of every segment and its subdivisions, allowing our clients to gain a deep understanding of the Cancer Gene Panel and Profiling Market (2023-28). We prioritize uncovering the pivotal factors that presently drive and will shape the industry’s growth moving forward. Our goal is to empower our esteemed clients by optimizing their end-user positioning and revenue generation through a thorough analysis of market size, share and all the latest market scope across diverse segmentation categories.

The Cancer Gene Panel and Profiling Market segmentation is enlisted below:

By Technology

• Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
• Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
• Microarray- Market Size & Forecast 2019-2029, USD Million
• Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
• Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million

By Application

• Oncology Research- Market Size & Forecast 2019-2029, USD Million
• Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
• Drug Development- Market Size & Forecast 2019-2029, USD Million
• Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million

By Cancer Type

• Breast Cancer- Market Size & Forecast 2019-2029, USD Million
• Lung Cancer- Market Size & Forecast 2019-2029, USD Million
• Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
• Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
• Others (Ovarian Cancer, Leukemia, etc.) — Market Size & Forecast 2019-2029, USD Million

By Cell Type

• Germline — Market Size & Forecast 2019-2029, USD Million
• Somatic — Market Size & Forecast 2019-2029, USD Million

By End-User

• Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
• Research Institutes- Market Size & Forecast 2019-2029, USD Million
• Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
• Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million

Research Institutes are poised to capture the potential share of the Global Cancer Gene Panel and Profiling Market in the coming years. 

Buy specific sections of the report directly from the Table of Contents — https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html

By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Cancer Gene Panel and Profiling Market Competitive Landscape

10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other.

Cancer Gene Panel and Profiling Industry News:

• 2023: Neo Genomics and Massive Bio announced a collaboration to leverage their expertise in biomarker testing, data analysis, machine learning, and biomarker and genomic profiling to accomplish a significant milestone within the field of oncology.

Request Customization – https://www.marknteladvisors.com/query/request-customization/cancer-gene-panel-profiling-market.html

Key Report Highlights   

• Market Dimensions & Projections
• Pricing Evaluation,
• Recent Strategic Moves by Companies,
• Primary Stakeholders,
• Analysis of Import and Export Trends,
• Competitive Landscape Assessment,
• Emerging Opportunities,
• Market Trends and Indicators

*Reports Delivery Format — Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Our Expertise is here to assist you : https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-gene-panel-profiling-market.html

Call Us — US Office: +1 628 895 8081, India Office: +91 120 4278433

Email — sales@marknteladvisors.com

Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Follow us – Facebook| LinkedIn| Twitter| Pinterest